Hypertension in diabetes: The role of the vasculature

Current Hypertension Reports

Volumn 6, Issue 2, 2004, Pages 90-97

  Stern, Naftali ^a   Marcus, Yonit ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADIPONECTIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOSYLATED PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEPTIN; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; POTASSIUM PROTON EXCHANGE PROTEIN; PROTEIN KINASE C; ROSIGLITAZONE; SOMATOMEDIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; DIABETES MELLITUS; DRUG MECHANISM; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MUSCLE CELL; NONHUMAN; OBESITY; PROTEIN FUNCTION; REVIEW; STRUCTURE ANALYSIS; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASODILATATION; ANIMAL; BLOOD VESSEL; DIABETIC ANGIOPATHY; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

ANIMALS; BLOOD VESSELS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; GLUCOSE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MYOCYTES, SMOOTH MUSCLE; VASCULAR DISEASES;

EID: 4644249250     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0082-9     Document Type: Review

References (51)

1. Major S.G. Blood pressure in diabetes mellitus: A statistical study.. Arch. Intern. Med. 1989 44 797
2. Ferris JB, O'Hare JA, Kelleher CCM, et al.: Diabetic control and the renin angiotensin system, catecholamines and blood pressure. Hypertension 1985, 7(Suppl2):II58.
3. Mäkimattila S, Yki-Järvinen H: Endothelial dysfunction in human diabetes. Curr Diabetes Rep 2002, 2: 6-36.
4. Steinberg HO, Brechtel G, Johnson A, et al.: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994, 94:1172-1179.
5. Baron AD, Zhu JS, Marshall S, et al.: Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol 1995, 269: 709-E715.
6. Zeng G, Nystrom FH, Racichandran LV, et al.: Roles for insulin signaling pathways related to production of nitric oxide in human vascular endothelial cell. Circulation 2000, 101: 539-1545.
7. Laakso M, Edelman SV, Brechtel G, Baron D: Decreased effect of insulin to stimulate muscle blood flow in obese men: a novel mechanism for insulin resistance. J Clin Invest 1990, 85: 844-1852.
8. Muniyappa R, Srinivas PR, Ram JL, et al.: Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 1998, 31:289-295.
9. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96:25-28.
10. Federici M, Menghini R, Mauriello A, et al.: Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 2002, 106: 66-472.
11. Kim F, Gallis B, Corson MA: TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol Cell Physiol 2001, 280:C1057-C1065.
12. Stuhlinger MC, Abbasi F, Chu JW, et al.: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002, 287:1420-1426.
13. Xu B, Chibber R, Ruggerio D, et al.: Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB 12003, 17:1289-1291.
14. Timimi FK, Ting HH, Haley EA, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998, 31:552-557.
15. Jensen-Urstad KJ, Richard PG, Rosfors JS, et al.: Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996, 45: 253-1258.
16. McNeill KL, Fontana L, Russell-Jones DL, et al.: Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation. J Am Coll Cardiol 2000, 35:1622-1627.
17. Stepp DW, Ou J, Ackerman AW, et al.: Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol 2002, 283:H750-H759.
18. Li L, Sawamura T, Renier G: Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 2003, 52:1843-1850.
19. Sakurai K, Sawamura T: Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress. J Pharmacol Sci 2003, 91:182-186.
20. Tan KC, Chow WS, Tam SC, et al.: Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 2002, 87: 63-568.
21. Miyazaki A, Nakayama H, Horiuchi S: Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med 2002, 12:258-262.
22. Sowers JR: Hypertension, angiotensin II, and oxidative stress. N Engl J Med 2002, 346:1999-2001.
23. Stern N, Sowers JR, Tuck ML: Pathophysiology of hypertension in diabetes mellitus. In A Textbook of Diabetes Mellitus, edn 3. Edited by LeRoit D, Taylor S, Olefsky J. 2003:1377-1400.
24. Coffey MJ, Natarajan R, Chumley PH, et al.: Catalytic consumption of nitric oxide by 12/15-lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. Proc Natl Acad Sci U S A 2001, 98:8006-8011.
25. Verbeke P, Perichon M, Friguet B, Bakala H: Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. Biochim Biophys Acta 2000, 1502:481-494.
26. Artwohl M, Graier WF, Roden M, et al.: Diabetic LDL triggers apoptosis in vascular endothelial cells. Diabetes 2003, 52:1240-1247.
27. Jiang ZY, Zhou QL, Chatterjee A, et al.: Endothelin-1 modulates insulin signalling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999, 48:1120-1130.
28. Cooper D, Stokes KY, Tailor A, Granger DN: Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc Toxicol 2002, 2:165-180.
29. Che W, Lerner-Marmarosh N, Huang Q, et al.: Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 2002, 90:1222-1230.
30. Okouchi M, Okayama N, Imai S, et al.: High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase. Diabetologia 2002, 45:1449-1456
31. Golovchenko I, Goalstone ML, Watson P, et al.: Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res 2000, 87:746-752.
32. Bayes-Genis A, Conover CA, Schwartz RS: The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000, 86:125-130.
33. Hsueh WA, Jackson S, Law RE: Control of vascular cell proliferation and migration by PPAR: a new approach to the macrovascular complications of diabetes. Diabetes Care 2001, 24:392-397.
34. Srivastava AK: High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes [review]. Int J Mol Med 2002, 9:85-89.
35. Ha SW, Bae JS, Yeo HJ, et al.: TGF-beta-induced protein beta ig-h3 is upregulated by high glucose in vascular smooth muscle cells. J Cell Biochem 2003, 88:774-782.
36. Bidder M, Shao JS, Charlton-Kachigian N, et al.: Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J Biol Chem 2002, 277:44485-44496.
37. Sheetz MJ, King GL: Molecular understanding of hyperglycermia's adverse effects for diabetic complications. JAMA 2002, 288:2579-2588.
38. Yasunari K, Kohno M, Kano H, et al.: Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation 1999, 99:1370-1378.
39. Motley ED, Kabir SM, Gardner CD, et al.: Lysophosphatidyl-choline inhibits insulin-induced Akt activation through protein kinase C-alpha in vascular smooth muscle cells. Hypertension 2002, 39(2 Pt 2):508-512.
40. Hsueh WA, Law RE: PPARgamma and atherosclerosis: effects on cell growth and movement. Arterioscler Thromb Vasc Biol 2001, 21:1891-1895.
41. Chen NX, Moe SM: Arterial calcification in diabetes. Curr Diab Rep 2003, 3:28-32.
42. Sowers JR: Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism. Diabetes 1996, 45(Suppl3):S47-S51.
43. Sowers JR: Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997, 29:691-699.
44. Gros R, Borkowski KR, Feldman RD: Human insulin-mediated enhancement of vascular beta-adrenergic responsiveness. Hypertension 1994, 23:551-555.
45. Vollenweider P, Randin D, Tappy L, et al.: Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994, 93: 365-2371.
46. Liu Y, Terata K, Rusch NJ, Gutterman DD: High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 2001, 89:146-152.
47. Vlassara H, Cai W, Crandall J, et al.: Inflammatory mediators are induced by dietary glycotoxins: a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 2002, 99: 5596-15601.
48. Fortuno A, Rodriguez A, Gomez-Ambrosi J, et al.: Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 2002, 143: 555-3560.
49. Verma S, Li SH, Wang CH, et al.: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003, 108:736-740.
50. Hattori Y, Suzuki M, Hattori S, Kasai K: Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003, 46:1543-1549.
51. Koshiyama H, Shimono D, Kuwamura N, et al.: Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 2001, 86:3452-3456.